资源 » 参考数据库 » 客户发表文献

至今，GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次，处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果，再次证明GenScript 有能力帮助业内科学家Make research easy.

An improved Tet-on system in microRNA overexpression and CRISPR/Cas9-mediated gene editing.

J Anim Sci Biotechnol. 2019-01;

KangKang，HuangLian，LiQing，LiaoXiaoyun，DangQuanjin，YangYi，LuoJun，ZengYan，LiLi，GouDe

Products/Services Used	Details	Operation
Catalog Antibody	The following primary antibodies were used: PDCD4 (Santa Cruz Biotechnology, Santa Cruz, CA, USA, SC-13054, 1:1,000), NFAT5 (Santa Cruz Biotechnology, SC-13035, 1:200), FLAG (GenScript, Piscataway, NJ, USA, A00013, 1:1,000)	Get A Quote

摘要

Tetracycline (Tet)-regulated expression system has become a widely applied tool to control gene activity. This study aimed to improve the Tet-on system with superior regulatory characteristics.